Blogging 23andMe’s consumer pharmacogenetics report no longer requires follow-up testing for certain medications August 18, 2020 Anthony Bell Leave a comment While the company’s new 510(k) cuts down some of the burden, consumers are still advised to consult their healthcare provider before making any changes to their treatments.
